Catapult exits FDAS
Catapult Venture Managers has sold Food and Drug Analytical Services (FDAS) to Tentamus UK, the UK subsidiary of German laboratory group Tentamus Group.
Catapult first invested in FDAS in 2004 when the company was established via its East Midlands Regional Venture Capital Fund.
Company
Based in BioCity, Nottingham, FDAS provides pharmaceutical quality control testing services. It offers full-contract testing services, including chemistry, microbiology, stability and development capabilities, to pharmaceutical companies.
The company employs 20 people.
People
Catapult Venture Managers - Jonathan Lowe (head of investor relations).
FDAS - Larissa Taylor (technical director).
Advisers
Vendor - Fraser Brown, Tom Gray, Peter Abel (legal); Smith Hodge & Baxter (financial due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds









